BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23839811)

  • 1. Cannabis use, addiction risk and functional impairment in youth seeking treatment for primary mood or anxiety concerns.
    Osuch E; Vingilis E; Ross E; Forster C; Summerhurst C
    Int J Adolesc Med Health; 2013; 25(3):309-14. PubMed ID: 23839811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychopathology among cannabis-dependent treatment seekers and association with later substance abuse treatment.
    Arendt M; Rosenberg R; Foldager L; Perto G; Munk-Jørgensen P
    J Subst Abuse Treat; 2007 Mar; 32(2):113-9. PubMed ID: 17306720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, correlates and comorbidity of DSM-IV Cannabis Use and Cannabis Use Disorders in Australia.
    Teesson M; Slade T; Swift W; Mills K; Memedovic S; Mewton L; Grove R; Newton N; Hall W
    Aust N Z J Psychiatry; 2012 Dec; 46(12):1182-92. PubMed ID: 22984111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders.
    Mojtabai R; Olfson M; Mechanic D
    Arch Gen Psychiatry; 2002 Jan; 59(1):77-84. PubMed ID: 11779286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comorbidity in 207 cannabis users in a specific outpatient setting].
    Guillem E; Arbabzadeh-Bouchez S; Vorspan F; Bellivier F
    Encephale; 2015 Jun; 41 Suppl 1():S7-12. PubMed ID: 25123065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation between perceived need for mental health treatment, DSM diagnosis, and quality of life: a Canadian population-based survey.
    Sareen J; Stein MB; Campbell DW; Hassard T; Menec V
    Can J Psychiatry; 2005 Feb; 50(2):87-94. PubMed ID: 15807224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psychiatric complications of cannabis use].
    Coscas S; Benyamina A; Reynaud M; Karila L
    Rev Prat; 2013 Dec; 63(10):1426-8. PubMed ID: 24579344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affect dysregulation in cannabis abusers: a study in adolescents and young adults.
    Dorard G; Berthoz S; Phan O; Corcos M; Bungener C
    Eur Child Adolesc Psychiatry; 2008 Aug; 17(5):274-82. PubMed ID: 18301941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autonomy, competence and relatedness and cannabis and alcohol use among youth in Canada: a cross-sectional analysis.
    Enns A; Orpana H
    Health Promot Chronic Dis Prev Can; 2020 Jun; 40(5-6):201-210. PubMed ID: 32529980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of treatment-seeking adolescents with opioid versus cannabis/alcohol use disorders.
    Subramaniam GA; Stitzer ML; Woody G; Fishman MJ; Kolodner K
    Drug Alcohol Depend; 2009 Jan; 99(1-3):141-9. PubMed ID: 18818027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proximal psychiatric risk factors for suicidality in youth: the Great Smoky Mountains Study.
    Foley DL; Goldston DB; Costello EJ; Angold A
    Arch Gen Psychiatry; 2006 Sep; 63(9):1017-24. PubMed ID: 16953004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Which psychiatric comorbidities in cannabis dependence during adolescence? Comparison of outpatients and controls].
    Dorard G; Bungener C; Phan O; Edel Y; Corcos M; Berthoz S
    Encephale; 2018 Feb; 44(1):2-8. PubMed ID: 27637871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transition to drug co-use among adolescent cannabis users: The role of decision-making and mental health.
    Lopez-Quintero C; Granja K; Hawes S; Duperrouzel JC; Pacheco-Colón I; Gonzalez R
    Addict Behav; 2018 Oct; 85():43-50. PubMed ID: 29843040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of common psychiatric problems among adolescent and young adult females: Focus on mood and anxiety.
    Black JJ; Rofey DL
    Best Pract Res Clin Obstet Gynaecol; 2018 Apr; 48():165-173. PubMed ID: 28970006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heavy cannabis users seeking treatment- prevalence of psychiatric disorders.
    Arendt M; Munk-Jørgensen P
    Soc Psychiatry Psychiatr Epidemiol; 2004 Feb; 39(2):97-105. PubMed ID: 15052390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of anxiety and mood disorders on craving and substance use among patients with substance use disorder: An ecological momentary assessment study.
    Fatseas M; Serre F; Swendsen J; Auriacombe M
    Drug Alcohol Depend; 2018 Jun; 187():242-248. PubMed ID: 29684892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abuse or dependence on cannabis and other psychiatric disorders. Madrid study on dual pathology prevalence.
    Arias F; Szerman N; Vega P; Mesias B; Basurte I; Morant C; Ochoa E; Poyo F; Babin F
    Actas Esp Psiquiatr; 2013; 41(2):122-9. PubMed ID: 23592072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Substance use, affective problems and personality traits: test of two association models].
    Chakroun N; Doron J; Swendsen J
    Encephale; 2004; 30(6):564-9. PubMed ID: 15738859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.